XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Millions
Total
Common Stock
Exchangeable Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Redeemable Convertible Preferred Stock
Series I Redeemable Convertible Preferred Stock
Series A Redeemable Convertible Preferred Stock
Temporary equity, beginning balance (in shares) at Dec. 31, 2020             165,182,000    
Temporary equity, beginning balance at Dec. 31, 2020             $ 2,557    
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of Series A redeemable convertible preferred stock, net of issuance costs (in shares)               2,120,000  
Issuance of Series A redeemable convertible preferred stock, net of issuance costs               $ 265  
Temporary equity, ending balance (in shares) at Dec. 31, 2021             167,302,000    
Temporary equity, ending balance at Dec. 31, 2021             $ 2,822    
Common stock, beginning balance (in shares) at Dec. 31, 2020   60,437,000              
Beginning balance at Dec. 31, 2020 $ (981) $ 0 $ 0 $ 351 $ 0 $ (1,332)      
Exchangeable share, beginning balance (in shares) at Dec. 31, 2020     689,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of common stock options (in shares)   1,051,000              
Exercise of common stock options 6     6          
Exercise of non-voting common stock warrants (in shares)   3,716,000              
Exercise of non-voting common stock warrants 68     68          
Amortization of non-voting common stock warrants 3     3          
Amortization of non-voting common stock issuable pursuant to subscription agreement 2     2          
Stock-based compensation 23     23          
Issuance of non-voting common stock in connection with subscription agreement (in shares)   464,000              
Issuance of non-voting common stock (in shares)   1,043,000              
Issuance of non-voting common stock 125     125          
Issuance of non-voting common stock in connection with business acquisitions (in shares)   2,105,000              
Issuance of non-voting common stock in connection with business acquisitions 255     255          
Issuance of restricted non-voting common stock in connection with business acquisitions (in shares)   269,000              
Issuance of restricted non-voting common stock (in shares)   450,000              
Foreign currency translation adjustments 0                
Net unrealized gain (loss) on available-for-sale marketable securities, net of tax (1)       (1)        
Net income (loss) (73)         (73)      
Common stock, ending balance (in shares) at Dec. 31, 2021   69,535,000              
Exchangeable share, ending balance (in shares) at Dec. 31, 2021     689,000            
Ending balance at Dec. 31, 2021 $ (573) $ 0 $ 0 833 (1) (1,405)      
Temporary equity, ending balance (in shares) at Dec. 31, 2022 167,302,000           167,302,000   0
Temporary equity, ending balance at Dec. 31, 2022 $ 2,822           $ 2,822   $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of common stock options (in shares)   149,000              
Exercise of common stock options 1     1          
Exercise of non-voting common stock warrants (in shares)   1,858,000              
Exercise of non-voting common stock warrants 34     34          
Modification of non-voting common stock warrants 17     17          
Stock-based compensation 33     33          
Issuance of non-voting common stock in connection with subscription agreement (in shares)   465,000              
Issuance of non-voting restricted stock in connection with business acquisitions (in shares)   223,000              
Foreign currency translation adjustments (2)       (2)        
Net unrealized gain (loss) on available-for-sale marketable securities, net of tax (2)       (2)        
Net income (loss) $ 428         428      
Common stock, ending balance (in shares) at Dec. 31, 2022 72,230,000 72,230,000              
Exchangeable share, ending balance (in shares) at Dec. 31, 2022 689,000   689,000            
Ending balance at Dec. 31, 2022 $ (64) $ 0 $ 0 918 (5) (977)      
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares)             (167,302,000)    
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering             $ (2,822)    
Issuance of Series A redeemable convertible preferred stock, net of issuance costs (in shares)                 5,833,000
Issuance of Series A redeemable convertible preferred stock, net of issuance costs                 $ 175
Accretion of Series A redeemable convertible preferred stock                 $ 2
Temporary equity, ending balance (in shares) at Dec. 31, 2023             0   5,833,000
Temporary equity, ending balance at Dec. 31, 2023             $ 0   $ 177
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of common stock options (in shares) 10,476,000 10,476,000              
Exercise of common stock options $ 6     6          
Stock-based compensation 2,812     2,812          
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares)   167,692,000              
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering 2,822     2,822          
Issuance of common stock in connection with initial public offering, net of underwriting discounts and offering costs (in shares)   14,100,000              
Issuance of common stock in connection with initial public offering, net of underwriting discounts and offering costs 392     392          
Conversion of exchangeable shares to common stock in connection with initial public offering (in shares)   688,000 (688,000)            
Forfeiture of exchangeable shares (in shares)     (1,000)            
Issuance of common stock upon settlement of restricted stock units (in shares)   33,334,000              
Exercise of common stock warrants (in shares)   7,431,000              
Common stock withheld or cancelled for tax obligation and net settlement (in shares)   (25,456,000)              
Common stock withheld or cancelled for tax obligation and net settlement (570)     (570)          
Foreign currency translation adjustments 5       5        
Net unrealized gain (loss) on available-for-sale marketable securities, net of tax 3       3        
Accretion of Series A redeemable convertible preferred stock $ (2)     (2)          
Repurchase and retirement of common stock (in shares) (1,448,551) (1,449,000)              
Repurchase and retirement of common stock $ (36)         (36)      
Net income (loss) (1,622)         (1,622)      
Other $ 4     4          
Common stock, ending balance (in shares) at Dec. 31, 2023 279,046,000 279,046,000              
Exchangeable share, ending balance (in shares) at Dec. 31, 2023 0   0            
Ending balance at Dec. 31, 2023 $ 3,750 $ 0 $ 0 $ 6,382 $ 3 $ (2,635)